PT283 – Greg McKee – Psychedelics for Nociplastic Pain

In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia. www.psychedelicstoday.com

Episode details come from the podcast's RSS feed.

Embed this episode

Attribution link and audio player

Ready to play

PT283 – Greg McKee – Psychedelics for Nociplastic Pain

0:00 1:11:34

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

THINK BIGGER, THINK BETTER Paul Gibbons THINK BIGGER, THINK BETTER presents the 21st century’s leading entrepreneurs, scientists, philosophers, public intellectuals, and business and political leaders as they discuss the most important issues of today. Join your host Paul Gibbons and his guests as they explore themes such as: progress and technology, reason and emotions, ethics and business leadership, science and health, media and society, politics and education, pseudoscience and marketing hype, neuroscience and decision making. To support us on Patreon, go to patreon.com/paulgibbons

Frequently asked questions

How long is this episode of Psychedelics Today?

This episode is 1 hour and 11 minutes long.

When was this Psychedelics Today episode published?

This episode was published on January 31, 2022.

Can I download this Psychedelics Today episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.